Alternative therapies and products are frequently developed to reduce the harm associated with tobacco use – in particular, cigarette smoking. Electronic nicotine delivery systems (ENDS) have become the most popular alternative. The dynamic and rapid growth of this market has led regulators and manufacturers to work together to preserve public health. Achieving market authorisation for your ENDS products provides reassurance of product quality to your customers.
Broughton Laboratories provided analytical support for the first ENDS product licensed as a medicinal product in the UK. In addition, we supported over 5,000 successful TPD applications. We deliver a collaborative service that fluently leads manufacturers through a compliant submission process.
Please select one of the following regulations to view the services we offer: